Source: Health Products and Food Branch (CA) Revision Year: 2021
OCTOSTIM Desmopressin acetate injection.
Route of Administration | Dosage Form / Strength | Nonmedicinal Ingredients |
---|---|---|
Intravenous, subcutaneous | 15 mcg/mL | Hydrochloric acid, purified water, sodium chloride |
Each mL of OCTOSTIM contains desmopressin acetate 15 mcg, with sodium chloride and hydrochloric acid to adjust the pH to 3.5, in water for injection.
OCTOSTIM is available in a 1 mL ampoule containing 15 mcg desmopressin. Ampoules are clear glass with a red identification ring and a blue dot indicating the cut area.
Marketing Informations | Authorization Dates |
---|---|
Authorization holder:
Ferring Inc., 200 Yorkland Blvd., Suite 500, North York, Ontario, M2J 5C1 244562 |
Date of revision:
March 17, 2021 |
Drug | Countries | |
---|---|---|
OCTOSTIM | Austria, Canada, Ecuador, Estonia, Spain, Finland, Hong Kong, Lithuania, Netherlands, New Zealand, Turkey |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.